VS

Vadakkarakurupath Sowmya

Active Director Director DIN 09131659
DIN 09131659 First appointment Apr 2021 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Vadakkarakurupath Sowmya

Data last updated:

Vadakkarakurupath Sowmya is a Director at Annmira Pharma India Private Limited (since 2021). The company operates in Chemicals.

DIN 09131659
Primary Designation Director
Industry Chemicals
First Appointment 01 Apr 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Annmira Pharma India Private Limited U24299KL2021PTC068386
Director01 Apr 20212021Active

Board colleagues of Vadakkarakurupath Sowmya

Directorship timeline

Open interactive timeline →
Annmira Pharma India Private Limited
Premium access

Shareholding and investment profile for Vadakkarakurupath Sowmya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vadakkarakurupath Sowmya

Vadakkarakurupath Sowmya currently holds 1 directorship: Annmira Pharma India Private Limited (Director, since 01 Apr 2021).

Vadakkarakurupath Sowmya was first appointed on 01 Apr 2021 as Director at Annmira Pharma India Private Limited.

The current boards of Vadakkarakurupath Sowmya's companies include Edayathuchirayil Chithambaran Rijo (Annmira Pharma India Private Limited), Gisha Alphy (Annmira Pharma India Private Limited), Remmi Chithambaran (Annmira Pharma India Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available